UBS-Copper ANTO sets 2026 TCRCs at zero...-20251222

Required Disclosures

This document has been prepared by UBS AG London Branch, an affiliate of UBS AG. UBS AG, its subsidiaries, branches and affiliates,including former Credit Suisse AG and its subsidiaries, branches and affiliates are referred to herein as "UBS".

For information on the ways in which UBS manages conflicts and maintains independence of its UBS Global Research product;historical performance information; certain additional disclosures concerning UBS Global Research recommendations; and terms andconditions for certain third party data used in research report, please visit https://www.ubs.com/disclosures. Unless otherwiseindicated, information and data in this report are based on company disclosures including but not limited to annual, interim, quarterlyreports and other company announcements. The figures contained in performance charts refer to the past; past performance is not areliable indicator of future results. Additional information will be made available upon request. UBS Securities Co. Limited is licensed toconduct securities investment consultancy businesses by the China Securities Regulatory Commission. UBS acts or may act as principalin the debt securities (or in related derivatives) that may be the subject of this report. This recommendation was finalized on: 22December 2025 06:55 AM GMT. UBS has designated certain UBS Global Research department members as Derivatives ResearchAnalysts where those department members publish research principally on the analysis of the price or market for a derivative, andprovide information reasonably sufficient upon which to base a decision to enter into a derivatives transaction. Where DerivativesResearch Analysts co-author research reports with Equity Research Analysts or Economists, the Derivatives Research Analyst isresponsible for the derivatives investment views, forecasts, and/or recommendations. Quantitative Research Review: UBS GlobalResearch publishes a quantitative assessment of its analysts' responses to certain questions about the likelihood of an occurrence of anumber of short term factors in a product known as the 'Quantitative Research Review'. Views contained in this assessment on aparticular stock reflect only the views on those short term factors which are a different timeframe to the 12-month timeframe reflectedin any equity rating set out in this note. For the latest responses, please see the Quantitative Research Review Addendum at the back ofthis report, where applicable. For previous responses please make reference to (i) previous UBS Global Research reports; and (ii) whereno applicable research report was published that month, the Quantitative Research Review which can be found at https://neo.ubs.com/quantitative, or contact your UBS sales representative for access to the report or the Quantitative Research Team on ubs-quant-answers@ubs.com. A consolidated report which contains all responses is also available and again you should contact your UBSsales representative for details and pricing or the Quantitative Research team on the email above.